DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells - Concepedia

Concepedia

Publication | Closed Access

DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells

122

Citations

30

References

2014

Year

Christine R. Klaus, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, J. Joshua Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock,

Journal of Pharmacology and Experimental Therapeutics

References

	Year	Citations

Page 1